An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J.Sarris J, et al.BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8.BMC Psychiatry. 2020.PMID: 31948424Free PMC article.
BACKGROUND: Medicinalcannabis has received increased research attention over recent years due to loosening global regulatory changes. Medicinalcannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-ind …
BACKGROUND: Medicinalcannabis has received increased research attention over recent years due to loosening global regulatory …
van den Elsen GAH, In 't Hout FEM, de Vries M, Olde Rikkert MGM, Kramers C, Verkes RJ.van den Elsen GAH, et al.Ned Tijdschr Geneeskd. 2019 May 3;163:D3629.Ned Tijdschr Geneeskd. 2019.PMID: 31120212Review.Dutch.
Medicinalcannabis The use of cannabis products for medical purposes is rapidly increasing in the Netherlands. ...A history of psychosis, relevant cardiac co-morbidity, recurrent falls, addiction problems, pregnancy and breastfeeding are all contra-ind …
Medicinalcannabis The use of cannabis products for medical purposes is rapidly increasing in the Netherlands. . …
Berger M, Amminger GP, McGregor IS.Berger M, et al.Aust J Gen Pract. 2022 Aug;51(8):586-592. doi: 10.31128/AJGP-04-21-5936.Aust J Gen Pract. 2022.PMID: 35908759Free article.
BACKGROUND: Anxiety is second most common reason for medicinalcannabis prescription in Australia and is being treated with both delta9-tetrahydrocannabinol (THC)-containing and cannabidiol (CBD)-dominant products. ...Despite the lack of robust supportive evidence, …
BACKGROUND: Anxiety is second most common reason for medicinalcannabis prescription in Australia and is being treated with bo …
Herbert A, Hardy J.Herbert A, et al.Aust J Gen Pract. 2021 Jun;50(6):363-368. doi: 10.31128/AJGP-02-21-5831.Aust J Gen Pract. 2021.PMID: 34059839Free article.Review.
BACKGROUND: Legislative change in recent years allows the prescription of medicinalcannabis for patients receiving palliative care. There appears to be widespread community support of its use in this context. OBJECTIVE: The aim of this article is to provide an over …
BACKGROUND: Legislative change in recent years allows the prescription of medicinalcannabis for patients receiving palliative …
Efron D, Taylor K.Efron D, et al.Int J Environ Res Public Health. 2023 Apr 7;20(8):5430. doi: 10.3390/ijerph20085430.Int J Environ Res Public Health. 2023.PMID: 37107712Free PMC article.Review.
Parents of children with developmental, behavioural and mental health disorders are increasingly asking whether medicinalcannabis might be a therapeutic option for their child. This paper presents the current evidence for medicinalcannabis in this po …
Parents of children with developmental, behavioural and mental health disorders are increasingly asking whether medicinalcannabis …
Kleeman-Forsthuber LT, Dennis DA, Jennings JM.Kleeman-Forsthuber LT, et al.J Am Acad Orthop Surg. 2020 Apr 1;28(7):268-277. doi: 10.5435/JAAOS-D-19-00438.J Am Acad Orthop Surg. 2020.PMID: 31800438Review.
Cannabis has gained widespread public advocacy since its legalization in several states with recent evidence suggesting that its self-reported use has increased in patients undergoing a primary total joint arthroplasty. ...
Cannabis has gained widespread public advocacy since its legalization in several states with recent evidence suggesting that its self …
Legare CA, Raup-Konsavage WM, Vrana KE.Legare CA, et al.Pharmacology. 2022;107(3-4):131-149. doi: 10.1159/000521683. Epub 2022 Jan 28.Pharmacology. 2022.PMID: 35093949Free article.Review.
While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited objective data supporting the use of crude materials (CBD oil, cannabis extracts, and/or cannabis itself). SUMMARY: In the pre …
While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited …
Kebede L, Masoomi Dezfooli S, Seyfoddin A.Kebede L, et al.Pharm Dev Technol. 2022 Feb;27(2):202-214. doi: 10.1080/10837450.2022.2035748. Epub 2022 Feb 7.Pharm Dev Technol. 2022.PMID: 35084279Review.
However, inconsistent dosage forms and erratic absorption levels prevent medicinalcannabis products from becoming mainstream recommendations for pain management. ...In this narrative view, the pharmacokinetics of cannabis products and possible methods of dru …
However, inconsistent dosage forms and erratic absorption levels prevent medicinalcannabis products from becoming mainstream …
Scott RJ, Scott IA.Scott RJ, et al.Intern Med J. 2025 Sep;55(9):1433-1444. doi: 10.1111/imj.70094. Epub 2025 Jun 3.Intern Med J. 2025.PMID: 40462510Free PMC article.Review.
Cannabis products are increasingly perceived and advertised as natural and safe treatments for a variety of conditions, including chronic non-cancer pain (CNCP). The number of prescriptions for medicinalcannabis (MC) currently averages >80 000 per month f …
Cannabis products are increasingly perceived and advertised as natural and safe treatments for a variety of conditions, including chr …
Ried K, Tamanna T, Matthews S, Sali A.Ried K, et al.J Sleep Res. 2023 Jun;32(3):e13793. doi: 10.1111/jsr.13793. Epub 2022 Dec 20.J Sleep Res. 2023.PMID: 36539991Clinical Trial.
This randomised crossover double-blind placebo-controlled 6-week trial aimed to assess the tolerability and effectiveness of the Entoura-10:15 medicinalcannabis oil on sleep in adults with insomnia. A total of 29 participants with self-reported clinical insomnia co …
This randomised crossover double-blind placebo-controlled 6-week trial aimed to assess the tolerability and effectiveness of the Entoura-10: …